By Crispin Dowler2015-12-18T12:43:00
NHS England’s chief financial officer has warned the board of a “substantial risk” that costs will ”significantly” outstrip the budget he has set for specialised commissioning next year, due to an ‘unprecedented stream’ of new and expensive drugs and treatments.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud